PBYI · Categories · Form 4

PBYI - SEC Form 4 insider transactions

Puma Biotechnology Inc (PBYI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PBYI

• 108d
  President and CEO Auerbach Alan H was granted 159,778 shares, increasing direct ownership by 2% to 7,305,729 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 108d
  Officer Hunt Douglas M was granted 49,394 shares, increasing direct ownership by 32% to 205,301 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 108d
  Chief Financial Officer Nougues Maximo F was granted 46,739 shares, increasing direct ownership by 24% to 240,023 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 151d
  President and CEO Auerbach Alan H sold $204,878 worth of shares (34,950 units at $5.86), decreasing direct ownership by 0.49% to 7,145,951 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 151d
  Officer Hunt Douglas M sold $52,696 worth of shares (8,987 units at $5.86), decreasing direct ownership by 5% to 155,907 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 151d
  Chief Financial Officer Nougues Maximo F sold $64,187 worth of shares (10,945 units at $5.86), decreasing direct ownership by 5% to 193,284 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 208d
  Director Miller Michael Patrick sold $97,228 worth of shares (20,000 units at $4.86), decreasing direct ownership by 27% to 54,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 322d
  Director Cesano Alessandra sold $90,909 worth of shares (27,000 units at $3.37), decreasing direct ownership by 39% to 41,850 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 334d
  Chief Financial Officer Nougues Maximo F sold $33,649 worth of shares (9,522 units at $3.53), decreasing direct ownership by 4% to 204,229 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 334d
  Officer Hunt Douglas M sold $27,624 worth of shares (7,817 units at $3.53), decreasing direct ownership by 5% to 164,894 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 334d
  President and CEO Auerbach Alan H sold $166,702 worth of shares (47,172 units at $3.53), decreasing direct ownership by 0.65% to 7,180,901 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 357d
  Director Wilson Troy Edward sold $36,720 worth of shares (10,800 units at $3.40), decreasing direct ownership by 20% to 43,550 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 357d
  Director Stuglik Brian M sold $27,459 worth of shares (8,100 units at $3.39), decreasing direct ownership by 8% to 94,958 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 357d
  Director Senderowicz Adrian sold $91,800 worth of shares (27,000 units at $3.40), decreasing direct ownership by 50% to 27,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 357d
  Director Moyes Jay M sold $74,800 worth of shares (22,000 units at $3.40), decreasing direct ownership by 29% to 53,322 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 357d
  Director Dorval Allison sold $39,474 worth of shares (11,610 units at $3.40), decreasing direct ownership by 13% to 75,390 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 357d
  Director Cesano Alessandra sold $41,310 worth of shares (12,150 units at $3.40), decreasing direct ownership by 15% to 68,850 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 361d
  Director Miller Michael Patrick was granted 27,000 shares, increasing direct ownership by 57% to 74,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 361d
  Director Senderowicz Adrian was granted 27,000 shares, increasing direct ownership by 100% to 54,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 361d
  Director Moyes Jay M was granted 27,000 shares, increasing direct ownership by 56% to 75,322 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 361d
  Director Dorval Allison was granted 27,000 shares, increasing direct ownership by 45% to 87,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 361d
  Director Stuglik Brian M was granted 27,000 shares, increasing direct ownership by 35% to 103,058 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 361d
  Director Wilson Troy Edward was granted 27,000 shares, increasing direct ownership by 99% to 54,350 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 361d
  Director Cesano Alessandra was granted 27,000 shares, increasing direct ownership by 50% to 81,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 483d
  Chief Financial Officer Nougues Maximo F was granted 61,456 shares, increasing direct ownership by 40% to 213,751 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 483d
  Chief Commercial Officer Ludwig Jeffrey Jerome was granted 47,841 shares, increasing direct ownership by 44% to 156,792 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 483d
  Officer Hunt Douglas M was granted 48,117 shares, increasing direct ownership by 39% to 172,711 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 483d
  President and CEO Auerbach Alan H was granted 198,399 shares, increasing direct ownership by 3% to 7,228,073 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 522d
  Chief Financial Officer Nougues Maximo F sold $32,232 worth of shares (10,227 units at $3.15), decreasing direct ownership by 6% to 152,295 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 522d
  Chief Commercial Officer Ludwig Jeffrey Jerome sold $29,743 worth of shares (9,437 units at $3.15), decreasing direct ownership by 8% to 108,951 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 522d
  Officer Hunt Douglas M sold $27,209 worth of shares (8,633 units at $3.15), decreasing direct ownership by 6% to 124,594 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 522d
  President and CEO Auerbach Alan H sold $106,657 worth of shares (33,841 units at $3.15), decreasing direct ownership by 0.48% to 7,029,674 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 664d
  Director Miller Michael Patrick sold $81,466 worth of shares (23,358 units at $3.49), decreasing direct ownership by 33% to 47,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 691d
  Chief Financial Officer Nougues Maximo F sold $15,382 worth of shares (4,156 units at $3.70), decreasing direct ownership by 2% to 162,522 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 691d
  Chief Commercial Officer Ludwig Jeffrey Jerome sold $9,615 worth of shares (2,598 units at $3.70), decreasing direct ownership by 2% to 118,388 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 691d
  Officer Hunt Douglas M sold $13,461 worth of shares (3,637 units at $3.70), decreasing direct ownership by 3% to 133,227 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 691d
  President and CEO Auerbach Alan H sold $81,128 worth of shares (21,920 units at $3.70), decreasing direct ownership by 0.31% to 7,063,515 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 706d
  Chief Financial Officer Nougues Maximo F sold $17,307 worth of shares (5,295 units at $3.27), decreasing direct ownership by 3% to 166,678 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 706d
  Chief Commercial Officer Ludwig Jeffrey Jerome sold $19,778 worth of shares (6,051 units at $3.27), decreasing direct ownership by 5% to 120,986 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 706d
  Officer Hunt Douglas M sold $14,215 worth of shares (4,349 units at $3.27), decreasing direct ownership by 3% to 136,864 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 706d
  President and CEO Auerbach Alan H sold $61,726 worth of shares (18,885 units at $3.27), decreasing direct ownership by 0.27% to 7,085,435 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 717d
  Director Wilson Troy Edward was granted 27,000 shares, increasing direct ownership by 7,714% to 27,350 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 717d
  Director Stuglik Brian M was granted 27,000 shares, increasing direct ownership by 55% to 76,058 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 717d
  Director Senderowicz Adrian was granted 27,000 shares (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 717d
  Director Miller Michael Patrick was granted 27,000 shares, increasing direct ownership by 39% to 95,358 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 717d
  Director Moyes Jay M was granted 27,000 shares, increasing direct ownership by 127% to 48,322 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 717d
  Director Dorval Allison was granted 27,000 shares, increasing direct ownership by 82% to 60,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 717d
  Director Cesano Alessandra was granted 27,000 shares, increasing direct ownership by 100% to 54,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 722d
  Director Wilson Troy Edward sold $89,902 worth of shares (27,000 units at $3.33), decreasing direct ownership by 99% to 350 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 722d
  Director Stuglik Brian M sold $33,528 worth of shares (9,900 units at $3.39), decreasing direct ownership by 17% to 49,058 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 722d
  Director Senderowicz Adrian sold $89,818 worth of shares (27,000 units at $3.33), closing all direct ownership in the company (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 722d
  Director Moyes Jay M sold $73,467 worth of shares (22,000 units at $3.34), decreasing direct ownership by 51% to 21,322 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 722d
  Director Dorval Allison sold $37,096 worth of shares (11,000 units at $3.37), decreasing direct ownership by 25% to 33,000 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 811d
  Auerbach Alan H was granted 6,577 shares, increasing direct ownership by 0.09% to 7,104,320 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 846d
  Wong Alvin F was granted 43,307 shares, increasing direct ownership by 44% to 141,241 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 846d
  Nougues Maximo F was granted 43,307 shares, increasing direct ownership by 34% to 171,973 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 846d
  Ludwig Jeffrey Jerome was granted 27,067 shares, increasing direct ownership by 27% to 127,037 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 846d
  Auerbach Alan H was granted 160,796 shares, increasing direct ownership by 2% to 7,097,743 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 846d
  Hunt Douglas M was granted 37,894 shares, increasing direct ownership by 37% to 141,213 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
• 881d
  Wong Alvin F sold $1,053 worth of shares (280 units at $3.76), decreasing direct ownership by 0.29% to 97,934 units (SEC Form 4)

  4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)

Other PBYI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends